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Abstract
Background: Ultrasonography has been extensively used in women suspected of having a gynecological malignancy.
The aim of this study is to evaluate the efficacy of 3D ultrasonography and power Doppler for discrimination between
benign and malignant endometrium in premenopausal women with abnormal uterine bleeding.
Methods: This cross-sectional study included 78 premenopausal women with abnormal uterine bleeding scheduled
for hysteroscopy and endometrial curettage. The endometrial thickness (ET), uterine artery pulsatility index (PI) and
resistance index (RI), and endometrial volume (EV) and 3D power Doppler vascularization index (VI), flow index (FI), and
vascularization flow index (VFI) were measured and compared with hysteroscopic and histopathologic findings.
Results: The ET (P <0.001), EV (P <0.001), and endometrial VI (P <0.001) and VFI (P = 0.043) were significantly increased in
patients with atypical endometrial hyperplasia and endometrial carcinoma (n = 10) than those with benign endometrium
(n = 68); whereas, the uterine artery PI and RI and endometrial FI were not significantly different between the two groups.
The best marker for discrimination between benign and malignant endometrium was the VI with an area under the ROC
curve of 0.88 at a cutoff value of 0.81 %.
Conclusion: 3D ultrasonography and power Doppler, especially endometrial VI, may be useful for discrimination between
benign and malignant endometrium in premenopausal women with abnormal uterine bleeding.
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Background
Endometrial carcinoma is the most common form of
gynecologic cancer in developed countries, and it is the
fourth most common malignant tumor among women
worldwide [1]. Abnormal uterine bleeding is usually the
first symptom; therefore, appropriate evaluation of
women with premenopausal or postmenopausal bleeding
will allow for early diagnosis of endometrial carcinoma
and the best opportunity for cure [2].
Ultrasonography has been extensively used in women
suspected of having a gynecological malignancy, especially
in ovarian [3] and endometrial [4] cancer. In fact, transva-
ginal ultrasonography is considered the initial imaging
procedure for evaluating abnormal vaginal bleeding due to
its ability to depict endometrial pathology, its widespread
availability, and its excellent safety profile and cost effect-
iveness [5].
Three-dimensional ultrasonography is a new imaging
technique that has become currently available in gyneco-
logic practice [6], specifically in gynecologic oncology [7].
In addition, 3D power-Doppler ultrasonography allows a
3D reconstruction of the vascular network and also
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calculating vascular indices based on the total and relative
amount of power Doppler information within the volume
of interest [8].
The aim of this study is to evaluate the efficacy of 3D
ultrasonography and power Doppler for discrimination
between benign and malignant endometrium in premen-
opausal women with abnormal uterine bleeding.
Methods
This cross-sectional study was conducted at the Depart-
ment of Obstetrics and Gynecology, Faculty of Medicine,
Cairo University, during the period from August 2013 to
May 2014. The study protocol was approved by the
Research Ethics Committee, and informed verbal consent
was obtained from all participants.
The study population consisted of 78 premenopausal
women with abnormal uterine bleeding scheduled for
hysteroscopy and endometrial curettage. They were
subjected to detailed history taking, complete general
and gynecological examination, routine pre-operative
laboratory investigations, and preliminary transvaginal
ultrasound. The exclusion criteria included uterine
fibroids, adenomyosis, endometrial polyps, and any
general diseases, hormones or medications that could
potentially affect pelvic blood flow.
Transvaginal ultrasound (Voluson 730; Kretz, Zipf,
Austria) examinations were performed within 24 h prior to
surgery. Using ultrasound in the 2D mode, the endometrial
thickness (ET) was measured as the thickest part (double
layer) in the sagittal plane (Fig. 1). Then, color Doppler was
activated and the flow velocity waveforms were obtained
from the ascending main branch of the uterine artery on
both sides of the internal os (Fig. 2). Three similar
consecutive waveforms of good quality were analyzed, and
the averaged right and left uterine artery pulsatility index
(PI) and resistance index (RI) were calculated.
The ultrasound was then switched to the 3D mode
with power Doppler. The setting conditions for this
study were standardized using a frequency at 3–9 MHz,
pulse repetition frequency at 0.6 kHz, gain at −4.0, and
wall motion filter at low 1. The Virtual Organ
Computer-Aided Analysis (VOCAL™) Imaging Program
for the 3D power Doppler histogram analysis was used
to measure the endometrial volume (EV) and 3D power
Doppler indices within the endometrium (Figs. 3 and 4).
Vascularization index (VI) measures the ratio of the
number of color voxels to the total number of voxels (%)
and represents the presence of blood vessels (vascularity).
Flow index (FI) measures the mean power Doppler signal
intensity (0–100) and represents the average intensity of
blood flow. Vascularization flow index (VFI) is calculated
by multiplying VI and FI (0–100) and represents a
combination of vascularity and flow intensity.
Hysteroscopic examination was performed routinely
before endometrial curettage using a rigid 30° hystero-
scope and a 4-mm-diameter diagnostic sheath (Karl Storz
GmbH & Co KG, Tuttlingen, Germany). The hystero-
scopic diagnosis was based on the following criteria:
atrophic endometrium-thin and homogeneous in appear-
ance; endometrial hyperplasia-thickened endometrium,
easily indented with pressure, with or without multipolyp
appearance; and endometrial carcinoma-irregular growth
with or without abnormal vascularization.
Endometrial sampling was carried out by formal
dilatation and curettage. The histopathological samples
were examined by two senior pathologists who determined
Fig. 1 Two-dimensional ultrasound measurement of endometrial thickness
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the final diagnosis. Ultrasonographic findings were
compared with hysteroscopic and histopathologic findings.
Statistical analysis
Data were expressed as mean ± SD or n (%) unless other-
wise indicated. Continuous data were compared using
Student t test or Mann-Whitney U test, as appropriate.
Receiver-operating characteristic (ROC) curve analysis
was used to evaluate the optimal cutoff value of ultra-
sound markers for prediction of malignant endometrial
lesions; based on an equivalent sensitivity and specificity,
and the highest value of the area under the curve
(AUC). A P value <0.05 was considered statistically sig-
nificant. The Statistical Package for the Social Science
(SPSS Inc., Chicago, IL, USA), version 16.0, was used for
data analyses.
Sample size calculation reveals that with a margin of
error of 4.99 % and a response distribution of 50 %, the
confidence level was 52 %; whereas with a margin of
error of 9.92 % and a response distribution of 50 %, the
confidence level was 84 %.
Results
Patients’ characteristics and histopathological diagnosis
are shown in Table 1. Of the 78 women included in the
study, 68 (87 %) had benign endometrium and 10 (13 %)
had malignant endometrium (atypical hyperplasia and
carcinoma). Hysteroscopic and histopathologic findings
were in agreement in almost all cases.
Fig. 2 Two-dimensional color Doppler of uterine artery flow velocity waveforms
Fig. 3 Virtual Organ Computer-Aided Analysis of the endometrium
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The age was significantly higher (P = 0.032) in patients
with malignant endometrium; however, there were no
significant differences in the parity (P = 0.954), weight (P =
0.952), height (P = 0.244), or body mass index (P = 0.248)
between the two groups. The ET (P <0.001), EV (P <0.001),
and endometrial VI (P <0.001) and VFI (P = 0.043) were
significantly increased in patients with malignant endomet-
rium; whereas, the uterine artery PI (P = 0.296) and
RI (P = 0.922) and endometrial FI (P = 0.474) were not
significantly different between the two groups (Table 2).
The diagnostic performance of the various ultrasound
markers is shown in Table 3. The best marker for dis-
crimination between benign and malignant endomet-
rium was the VI with an AUC of 0.88 at a cutoff value of
0.81 %. The sensitivity, specificity, positive predictive
value (PPV), negative predictive value (NPV), likelihood
ratio of a positive test (LR+), and likelihood ratio of a
negative test (LR−) for endometrial VI at 0.81 % (90 %,
88 %, 53 %, 98 %, 7.50, and 0.11, respectively) were
higher than those for ET at 19 mm (80 %, 72 %, 30 %,
96 %, 2.86, and 0.28, respectively), EV at 8 cm3 (90 %,
79 %, 39 %, 98 %, 4.29, and 0.13, respectively) and endo-
metrial VFI at 0.22 (60 %, 68 %, 23 %, 92 %, 1.88, and
0.59, respectively).
Discussion
To the best of our knowledge and review of literature,
this is the first study to evaluate the efficacy of 3D ultra-
sonography and power Doppler for discrimination be-
tween benign and malignant endometrium in women
Fig. 4 Three-dimensional power Doppler flow indices of the endometrium
Table 1 Patients’ characteristics and histopathological diagnosis
(n = 78)
Characteristic Value
Age (y) 47.46 ± 2.94
Parity 4.18 ± 1.18
Weight (kg) 87.79 ± 11.49
Height (cm) 157.10 ± 5.50
BMI (kg/m2) 35.53 ± 2.09
Endometrial histopathology; n (%)
Normal endometrium 20 (25.64)
Simple hyperplasia 25 (32.05)
Distorted proliferative 16 (20.51)
Atrophic endometrium 7 (8.97)
Atypical hyperplasia 4 (5.13)
Adenocarcinoma 6 (7.69)
BMI body mass index
Table 2 Characteristics of patients with benign and malignant
endometrium
Characteristic Benign (n = 68) Malignant (n = 10) P value
Age (y) 46.88 ± 1.95 48.43 ± 2.99 0.032a
Parity 4.18 ± 1.21 4.20 ± 1.03 0.954
Weight (kg) 87.76 ± 10.74 88.00 ± 16.44 0.952
Height (cm) 157.38 ± 5.80 155.20 ± 1.81 0.244
BMI (kg/m2) 35.29 ± 1.84 36.62 ± 8.42 0.248
ET (mm) 7.615 ± 5.493 21.400 ± 9.489 <0.001a
Uterine artery PI 1.847 ± 0.638 2.080 ± 0.755 0.296
Uterine artery RI 1.140 ± 1.583 1.190 ± 0.796 0.922
EV (cm3) 3.410 ± 2.728 7.534 ± 3.622 <0.001a
Endometrial VI (%) 0.310 ± 0.418 1.005 ± 0.597 <0.001a
Endometrial FI (0–100) 22.897 ± 4.547 24.212 ± 9.562 0.474
Endometrial VFI (0–100) 0.100 ± 0.157 0.204 ± 0.072 0.043a
BMI body mass index, ET endometrial thickness, PI pulsatility index,
RI resistance index, EV endometrial volume, FI flow index, VI vascularization
index, VFI vascularization flow index
aStatistically significant
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with premenopausal bleeding. Several previous studies
have evaluated the role of 3D ultrasonography/power
Doppler for the investigation of patients with postmeno-
pausal bleeding.
Our results showed that the ET, EV, and endometrial
VI and VFI were significantly increased in patients with
malignant endometrium than those with benign endo-
metrium; whereas, the uterine artery PI and RI and
endometrial FI were not significantly different between
the two groups. The best parameter for discrimination
between benign and malignant endometrium was the VI
with an AUC of 0.88 at a cutoff value of 0.81 %.
In agreement with our results, Mercé et al. [9] and
Alcazar and Galvan [10] found that the flow indices were
superior to EV for discrimination between endometrial
carcinoma and endometrial hyperplasia, and between
benign and malignant endometrium, respectively. The best
predictor for endometrial cancer was VI. Odeh et al. [11],
however, found that EV was superior to the flow indices for
discrimination between hyperplasia/malignant endomet-
rium and benign endometrium other than hyperplasia.
Epstein et al. [12] estimated the color content of the
endometrium subjectively by choosing the most vascu-
larized area and applying computer analysis to that area.
They concluded that power Doppler analysis can con-
tribute to a correct diagnosis of endometrial cancer in
women with postmenopausal bleeding. Makled et al.
[13] also concluded that 3D power Doppler measure-
ments may be useful for distinguishing between benign
endometrial lesions and endometrial carcinoma in
women with postmenopausal bleeding.
Kurjak et al. [14] and Kupesic et al. [15] reported the
use of volume measurements and power Doppler in
diagnosing endometrial and adnexal malignancies; they
found significant differences in the volume of malig-
nant and benign lesions. They suggested that a
combination of morphologic criteria and 3D power
Doppler findings could identify endometrial lesions
with sensitivity and specificity of 89 and 97 %,
respectively.
Galván et al. [16] found that EV and VI were inde-
pendently related to myometrial infiltration and tumor
stage in endometrial carcinoma; VI was independently
associated with tumor grade and EV correlated with
lymph node metastases. Saarelainen et al. [17] also sug-
gested that endometrial and, to a lesser degree, myome-
trial vascular indices and EV correlate with the depth of
myometrial invasion in endometrial carcinoma.
Contrary to our results, Lieng et al. [18] did not find
differences in 3D power Doppler indices between
women with endometrial polyps and endometrial cancer
before and after contrast enhanced examination.
Opolskiene et al. [19] also concluded that, although 3D
power Doppler indices were significantly higher in
women with endometrial cancer as compared with those
with benign pathology, the diagnostic performance of
3D ultrasound imaging was not superior to that of ET as
measured by 2D ultrasound examination.
De Smet et al. [20] analyzed the correlation between EV
and myometrial infiltration in a series of 97 women with
endometrial cancer. They found that the predicted prob-
ability of deep myometrial infiltration increased when the
ET increased, while this probability decreased when EV
increased. This could be explained by non-linear effects.
The differences in results between our study and previ-
ous studies can almost certainly be explained by substan-
tial differences in study populations and study design.
There are differences in menopausal status, use of hor-
mone replacement therapy, rate of endometrial cancer,
and mix of benign histologies. There are also differences
in the methods used to determine diagnostic performance
of ultrasound markers. The relatively high rate of endo-
metrial carcinoma and atypical hyperplasia in our study
can be explained by exclusion of other causes of premeno-
pausal bleeding in the study population.
Conclusions
Three-dimensional ultrasonography and power Doppler,
especially endometrial VI, may be useful for discrimin-
ation between benign and malignant endometrium in
premenopausal women with abnormal uterine bleeding
before resorting to invasive procedures such as hysteros-
copy and endometrial curettage. However, due to our
relatively small sample size, further studies in larger
series are needed to confirm these data.
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likelihood ratio of a positive test, LR likelihood ratio of a negative test
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